Previous Close | 3.5200 |
Open | 3.4600 |
Bid | 3.3200 x 0 |
Ask | 3.4200 x 0 |
Day's Range | 3.4600 - 3.4800 |
52 Week Range | 1.9100 - 5.4500 |
Volume | |
Avg. Volume | 0 |
Market Cap | 268.01M |
Beta (5Y Monthly) | 0.98 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.6700 |
Earnings Date | May 13, 2024 - May 17, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 32.71 |
The analysts covering Sutro Biopharma, Inc. ( NASDAQ:STRO ) delivered a dose of negativity to shareholders today, by...
SOUTH SAN FRANCISCO, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced the pricing of an underwritten offering of 14,478,764 shares of its common stock at a price of $5.18 per share. The gross proceeds from this offering are expected to be approximately $75.0 million, before deducting underwriting discounts and commissi
Full Year Earnings Reveal Strong Revenue Growth but Operational Challenges Persist